Scottish Brain Sciences (SBS) has opened a new clinical research centre at ONE BioHub in Aberdeen, marking a significant step forward in early Alzheimer’s research and trial accessibility across Scotland.
Professor Craig Ritchie, CEO and Founder of SBS, said: “The people of the north-east deserve early access to breakthroughs in brain health and dementia research. This new site will help ensure that people here can take part in trials, receive advanced assessments, and contribute to discoveries that could change the future of Alzheimer’s disease.”
He added: “Inviting one of our research participants to officially open this centre reflects our belief that progress begins and ends with the people who volunteer to take part. They are the beating heart of discovery.”
The Aberdeen facility becomes SBS’s third research site, joining its Edinburgh headquarters and St Andrews hub. Located within ONE BioHub, a launchpad for high-growth life sciences companies, the centre will support studies focused on early diagnosis, intervention and precision trials for Alzheimer’s and related conditions.
Lynne Carroll, a local research participant who officially opened the site, explained: “It took several years to receive my Alzheimer’s diagnosis, and that is the reality for so many people. By being part of research that aims to detect and treat Alzheimer’s earlier, I hope I can help make the path a little clearer for others in the future.”
Dr Deborah O’Neil, Chair of ONE Life Sciences and BioAberdeen Ltd, said: “We are delighted that Scottish Brain Science is expanding at ONE BioHub. Their focus on advancing understanding and treatment of neurological conditions adds important strengths to our growing life sciences cluster.”
The centre was officially opened on 14th November and is expected to play a key role in Scotland’s life sciences growth strategy.
